Acquirer Profile
AbbVie Acquisitions & Deals (2026)
Pharmaceuticals
Deals tracked
3
Combined value
$815M
Primary sector
Pharmaceuticals
Active
2026
FireStrike tracks every AbbVie acquisition, merger, and strategic investment in real time. This page covers 3 AbbVie deals totaling $815M in disclosed deal value, spanning Pharmaceuticals. Data covers 2026.
AbbVie Acquisitions — Full List
| Target company | Announced | Source |
|---|---|---|
Haisco Pharmaceutical Group Pharmaceuticals | Apr 2026 | |
Suzhou Zelgen Biopharmaceutical Pharmaceuticals | Jan 2026 | |
Revolution Medicines Biotech | Jan 2026 |
AbbVie Acquisitions — FAQ
How many acquisitions has AbbVie made?
AbbVie has made 3 acquisitions and deals tracked on FireStrike, totaling $815M in combined deal value.
What sectors does AbbVie acquire in?
AbbVie primarily acquires in Pharmaceuticals.
What is AbbVie's most recent acquisition?
AbbVie's most recent tracked acquisition is Haisco Pharmaceutical Group for $715M, announced Apr 2026.
Get every AbbVie deal in your inbox
FireStrike tracks M&A, IPOs, and fundraises daily — free.
Start tracking free →